Research Uncovers Impact of Disseminated Cancer on Aneurysm Repair Outcomes

Strategic Insights -

A study published in the journal Vascular has explored the impact of preoperative disseminated cancer on the 30-day outcomes of endovascular aneurysm repair (EVAR) for non-ruptured abdominal aortic aneurysms (AAAs). Researchers from George Washington University analyzed data from the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) database from 2012 to 2022 to identify patients who underwent infrarenal EVAR. The study found that while EVAR is relatively safe in terms of short-term outcomes in patients with disseminated cancer, the long-term prognosis for these patients needs further investigation.

Key Takeaways:

  • Disseminated cancer may complicate decision-making processes for major surgical interventions, including EVAR for AAA.
  • The postoperative outcomes of EVAR in patients with disseminated cancer have not been well-established.
  • The study found that EVAR is relatively safe in terms of short-term outcomes in patients with disseminated cancer.
  • However, the long-term prognosis for these patients needs further investigation.
  • The study used data from the ACS-NSQIP database from 2012 to 2022.
  • Patients who underwent infrarenal EVAR were identified and analyzed in the study.
  • Exclusion criteria included age.
  • The study included patients with disseminated cancer who underwent EVAR and were propensity-score matched with controls.

Statistics:

  • 2012-2022: The study period for the ACS-NSQIP database used in the analysis.
  • 30 days: The short-term outcomes evaluation period for the study.
  • 2012: The starting year of the study period.
  • 2022: The ending year of the study period.
  • Infrarenal EVAR: The type of endovascular aneurysm repair procedure analyzed in the study.
  • AAAs: The condition being treated with EVAR in the study.
  • Disseminated cancer: The condition that may complicate decision-making processes for EVAR in AAA patients.

Sources:

  • "Endovascular Aneurysm Repair for Patients With Disseminated Cancer: a Propensity-score Matched Study From Acs-nsqip Database From 2012-2022" (Vascular, 2025)
  • NewsRx: Cancer Weekly, August 5, 2025, p 242.